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Abstract: Four new bisabolane-type sesquiterpenoids, aspergiterpenoid A (1), (−)-sydonol 
(2), (−)-sydonic acid (3), and (−)-5-(hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H- 
pyran-2-yl)phenol (4) together with one known fungal metabolite (5) were isolated from 
the fermentation broth of a marine-derived fungus Aspergillus sp., which was isolated from 
the sponge Xestospongia testudinaria collected from the South China Sea. Four of them 
(1–4) are optically active compounds. Their structures and absolute configurations were 
elucidated by using NMR spectroscopic techniques and mass spectrometric analysis, and 
by comparing their optical rotations with those related known analogues. Compounds 1–5 
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showed selective antibacterial activity against eight bacterial strains  with the MIC 
(minimum inhibiting concentrations) values between 1.25 and 20.0 µM. The cytotoxic, 
antifouling, and acetylcholinesterase inhibitory activities of these compounds were also 
examined. 
Keywords: bisabolane-type sesquiterpenoid; antibacterial; sponge-derived fungus; 
Aspergillus sp. 
 
1. Introduction 
Several bisabolane-type phenolic sesquiterpenoids have been isolated from marine materials,  
such as the gorgonian coral Pseudopterogorgia rigida [1], the sponges Didiscus flavus [2] and 
Myrmekioderma styx [3], the marine-derived fungi Verticillium tenerum [4], Aspergillus sp. [5] and 
Aspergillus sydowii [6]. These compounds have received much attention because of their multiple potent 
biological activities including the acetylcholinesterase inhibitory activity [7], antioxidant activity [8], 
cytotoxic activity [9], and antibacterial activity [10]. 
As part of our ongoing investigation on new natural antibacterial, cytotoxic, and nontoxic antifouling 
agents from marine fungi in the South China Sea [5,11–13], the EtOAc extract of a fermentation  
broth of the fungus Aspergillus sp. isolated from the sponge Xestospongia testudinaria attracted our 
attention because the extract showed significant antibacterial activity. The crude EtOAc extract  
of the fungal culture was subjected to silica gel column chromatography, Sephadex LH-20 and  
further semi-preparative HPLC, and this led to the isolation of five bisabolane-type sesquiterpenoids,  
including four new compounds, aspergiterpenoid A (1), (−)-sydonol (2), (−)-sydonic acid (3), 
(−)5-(hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4), and one known 
compound, (Z)-5-(hydroxymethyl)-2-(6′-methylhept-2′-en-2′-yl)phenol (5) [14]. Their structures   
were elucidated using NMR spectroscopic techniques and mass spectrometric analysis, and the  
absolute configurations of compounds 1–3 were confirmed as R by comparing the optical rotations with 
(+)-sydonic acid, while compound 4 was confirmed as S using the same method. The antibacterial, 
cytotoxic, antifouling, and acetylcholinesterase inhibitory activities of these compounds (1–5) were 
examined. Compounds 1–5 exhibited selective antibacterial activity against six pathogenic bacteria and 
two marine bacteria. Compound 4 showed a significant inhibitory effect on larval settlement of the 
barnacle Balanus amphitrite, while compound 5 was found to have an obvious toxic effect on the larvae. 
2. Results and Discussion  
Aspergiterpenoid A (1) was isolated as optically active white powder, [α]
25
D −4.7 (c 3.21, CHCl3). 
The molecular formula of C15H24O2 was confirmed by HREIMS that displayed an [M]
•+ m/z of 236.1769 
(calcd. 236.1771). The IR absorption bands indicated the existence of hydroxyl functionality (3397 cm
−1). 
The 
1H NMR spectrum of 1 showed two exchangeable proton signals at δH 1.66 and 1.71 (validated by 
D2O change assay), one A2B2 spin system assignable to a 1,4-disubstitued benzene ring at δH 7.43 (2H, 
dd, 8.4, 1.8), 7.34 (2H, dd, 8.4, 1.8) (Table 1). The 
1H NMR spectrum revealed the presence of other Mar. Drugs 2012, 10    
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signals including two doublet methyl groups [H3-12 (δH 0.81), H3-13 (δH 0.81), one singlet methyl group 
[H3-14 (δH 1.55)], four methylenes [H2-15 (δH 4.69), H2-8 (δH 1.77), H2-9 (δH 1.12 and 1.26), and H2-10 
(δH 1.12)], and one methine [H-11 (δH 1.47)]. Thirteen carbon signals observed in the 
13C NMR 
spectrum (Table 1) indicated that there is a 1,4-disubstitued benzene ring in compound 1. Detailed 
analysis of the 
1H and 
13C NMR spectra revealed that 1 is a bisabolane-type sesquiterpenoid, which is 
similar to sydonol [15]. The main difference between the spectra of 1 and sydonol was the A2B2 spin 
system in 1 instead of ABX spin system in sydonol, suggesting that the phenolic hydroxyl group was 
missing in 1. Detailed assignments for carbons and protons were unambiguously accomplished by 
analysis of 2D NMR spectral data, and the planar structure of 1 was confirmed and is shown in Figure 1. 
Interestingly, the optical rotation value for 1 was [α]
25
D −4.7 (c 3.21, CHCl3), contrary to that of sydonol 
([α]
20
D +7.2 (c 1.0, MeOH)) [15]. On the basis of the absolute configurations of the co-metabolites 2  
and 3 and a shared biogenesis with these two compounds, the configuration of 1 should be assigned  
as 7R. It is noteworthy to mention that metabolite 1 represents the rare example of a bisabolane-type 
sesquiterpenoid possessing a 1,4-disubstitued benzene ring isolated from marine organisms. 
Table 1. NMR spectroscopic data (600 MHz, CDCl3) of Aspergiterpenoid A (1). 
Position  δC, mult  δH (J in Hz) 
1 147.8,  C  – 
2  125.1, CH  7.43, dd (8.4, 1.8) 
3  127.0, CH  7.34, dd (8.4, 1.8) 
4 139.1,  C  – 
5  127.0, CH  7.34, dd (8.4, 1.8) 
6  125.1, CH  7.43, dd (8.4, 1.8) 
7 74.8,  C  – 
8 44.4,  CH2 1.77,  m 
9 21.8,  CH2  1.26, m; 1.12, overlapped 
10 39.3,  CH2 1.12,  overlapped 
11 27.9,  CH  1.47,  m 
12 22.6,  CH3  0.81, d (6.6) 
13 22.7,  CH3 0.81,d  (6.6) 
14 30.3,  CH3 1.55,  s 
15 65.2,  CH2  4.69, d (3.0) 
7–OH   1.71,  s 
15–OH   1.66,  brs Mar. Drugs 2012, 10    
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Figure 1. Structures of compounds 1–5. 
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The spectroscopic data of compounds 2 and 3 were almost identical to those of (+)-sydonol and 
(+)-sydonic acid, respectively. Their opposite optical rotation values indicated that 2 and 3 were the 
enantiomers of (+)-sydonol and (+)-sydonic acid, respectively. (+)-Sydonol possessing the positive 
optical rotation value, ([α]
20
D +7.2 (c 1.0, MeOH)), was isolated from a terrestrial Aspergillus sp.  
by Nukina and co-workers in 1981 and exhibited antifungal activity against Cochliobolus lunata 
(IFO6299) [15]. Sydonic acid was isolated from the fungus A. sydowi in 1978 as a racemate [16], while 
(+)-sydonic acid ([α]
25
D +2.73 (c 2.30, MeOH)) was isolated from Glonium sp. in 2009 [17]. However, 
in our case, the optical rotation values of 2 and 3 were [α]
25
D −3.6 (c 3.70, CHCl3) and [α]
25
D −2.0  
(c 1.03, CHCl3), respectively. Since there was only one chiral carbon in every compound, the absolute 
configuration of these two compounds (2 and 3) were also established to be R. Interestingly, (+)-sydonic 
acid had also been recently isolated from a coral-derived Aspergillus sp. [5], this fact suggested that 
fungus isolated from different marine organisms might produce different stereochemistry compounds. 
(−)-5-(Hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4) was identified as 
the enantiomer of deoxygenated (+)-sydonol, which was a stereoselective synthesis product possessing 
the positive optical rotation value, [α]
20
D +40 (c 2.2, CHCl3) [18]. This compound was also isolated from 
the fungus Pinus strobus in 2011 as a racemate [14]. In this study, the optical rotation of 4 was detected 
as [α]
25
D −2.7 (c 1.05, CHCl3). As there was just one chiral carbon, the absolute stereochemistry of 4 was 
established to be S.  
The antibacterial activity of compounds 1–5 was evaluated by the microplate assay [19] against eight 
bacterial strains, e.g., six pathogenic bacteria Staphylococcus albus, Bacillus subtilis, Bacillus cereus, 
Sarcina lutea,  Escherichia coli,  Micrococcus tetragenus, and two marine bacterial strains   
Vibrio Parahaemolyticus and Vibrio anguillarum (Table 2). Compound 1 showed weak antibacterial 
activity against E. coli and M. tetragenus. Compounds 2 and 4 exhibited selective antibacterial activity. 
Compound 2 exhibited strong inhibitory activity on S. albus and M. tetragenus with the MIC (minimum 
inhibiting concentrations) values of 5.00 and 1.25 µM, respectively, and 4 on S. albus and B. subtilis 
with the MIC values of 5.00 and 2.50 µM, respectively. Compounds 3 and 5 showed a broad spectrum of 
antibacterial activity. Compound 5 inhibited five pathogenic bacteria except for S. lutea, and 3 exhibited 
significant inhibiting activity to four pathogenic bacteria and uniquely against two marine bacteria, Mar. Drugs 2012, 10    
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especially to S. lutea with the MIC value of 2.50 µM, which was similar to ciprofloxacin used as a 
positive control. 
Table 2. Tests of MIC (μM) for compounds 1–5 against eight bacteria. 
Strains 
Compounds 
1 2 3 4 5  Ciprofloxacin
Staphylococcus albus >20.0 5.00  >20.0 5.00  20.0  0.312 
Bacillus subtilis >20.0 >20.0 2.50  2.50  10.0  1.25 
Bacillus cereus >20.0 >20.0 >20.0 >20.0 10.0  0.625 
Sarcina lutea  >20.0 >20.0 2.50 >20.0 >20.0 2.50 
Escherichia coli  20.0 20.0 5.00  >20.0 10.0  0.625 
Micrococcus tetragenus  10.0 1.25 20.0  >20.0 10.0  0.312 
Vibrio Parahaemolyticus >20.0 >20.0 10.0  >20.0 >20.0 0.160 
Vibrio anguillarum  >20.0 >20.0 5.00 >20.0 >20.0 0.160 
The isolated compounds 1–5 were also evaluated against the larval settlement of the barnacle Balanus 
amphitrite according to literature procedures [20]. Compound 4 inhibited larval settlement completely at a 
concentration of 25.0 μg/mL. However, compound 5 was found to have an obvious toxic effect on the 
larvae at this concentration. The other three compounds did not display antifouling activity at the same 
concentration. This is the first report of antifouling activity for this class of metabolites. 
Compounds 1–5 were found to be weakly cytotoxic (IC50 > 50 μg/mL) against HL-60 human 
promyelocytic leukemia and A-549 human lung carcinoma cell lines. The acetylcholinesterase 
inhibitory activity of compounds 1–5 was also evaluated, but none of the compounds exhibited 
obviously inhibitory activity. 
3. Materials and Methods 
3.1. General Experimental Procedures 
Optical rotations were measured on a JASCO P-1020 digital polarimeter. IR spectra were recorded on 
a Nicolet Nexus 470 spectrophotometer. 
1H and 
13C NMR spectra were recorded on a JEOL Eclips-600 
spectrometer at 600 MHz for 
1H and 150 MHz for 
13C in CDCl3 or DMSO-d6. Chemical shifts δ are 
reported in ppm, using TMS as internal standard and coupling constants (J) are in Hz. ESIMS and 
HRESIMS and APCIMS were measured on a Q-TOF Ultima Global GAA076 LC mass spectrometer. 
HREIMS were measured on a Thermo MAT95XP High Resolution mass spectrometer and EIMS 
spectra on a Thermo DSQ EI-mass spectrometer. Silica gel (Qing Dao Hai Yang Chemical Group  
Co.; 200–300 mesh), octadecylsilyl silica gel (Unicorn; 45–60 μm) and Sephadex LH-20 (Amersham 
Biosciences) were used for column chromatography (CC). Precoated silica gel plates (Yan Tai Zi Fu 
Chemical Group Co.; G60, F-254) were used for thin layer chromatography (TLC). Semi-preparative 
HPLC was performed on a Waters 1525 system using a semi-preparative C18 (Kromasil 7 μm,  
10 × 250 mm) column coupled with a Waters 2996 photodiode array detector, at a flow rate of 2.0 mL/min. Mar. Drugs 2012, 10    
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3.2. Fungal Material 
The fungal strain Aspergillus sp. was isolated from a piece of tissue from the inner part of the freshly 
collected sponge Xestospongia testudinaria, which was collected from the Weizhou coral reef in the 
South China Sea in September, 2008. The strain was deposited in the Key Laboratory of Marine Drugs, 
the Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, 
Qingdao, PR China, with the access code ZJ-2008004. The fungal strain was cultivated in 50 L liquid 
medium in 125 Erlenmeyer flasks each containing 400 mL medium (10.0 g of glucose, 2.0 g of yeast 
extract, 2.0 g of peptone in 1 L of seawater) at 27 °C without shaking for 4 weeks. 
3.3. Identification of Fungus 
The fungus was identified according to its morphological characteristics and a molecular biological 
protocol by 16s RNA amplification and sequencing of the ITS region. The sequence data have been 
submitted to GenBank, accession number HM565949. The fungal strain was identified as Aspergillus sp. 
3.4. Extraction and Isolation 
The fungal cultures were filtered through cheesecloth, and the filtrate was extracted with EtOAc  
(3 × 50 L, 12 h each). The organic extracts were concentrated in vacuo to yield an oily residue (3.2 g), 
which was subjected to silica gel column chromatography using mixtures of petroleum ether and ethyl 
acetate to yield five fractions (Fr.1–Fr.5). Fr.2 was further purified by Sephadex LH-20 chromatography 
eluting with mixtures of CHCl3 and MeOH (1:1), and then using semi-preparative HPLC with a C18 
(Kromasil 7 μm, 10 × 25 mm) column at a flow rate of 2.0 mL/min (7:3 MeOH/H2O; UV detection at 
210 nm, tR of 1: 25–26 min, 2: 24–25 min) to yield compounds 1 (6.7 mg) and 2 (2.7 mg). Fr.3 was 
further purified by Sephadex LH-20 chromatography with mixtures of petroleum ether-CHCl3-MeOH 
(2:1:1) and CHCl3-MeOH (1:1) to obtain compounds 3 (50.6 mg), 4 (8.0 mg) and 5 (7.5 mg). 
Aspergiterpenoid A (1): white powder; [α]
25
D −4.7 (c 3.21, CHCl3); UV (MeOH) λmax 194.6, 216.9, 
260.4 nm; IR (KBr) νmax 3397, 3115, 2946, 2872, 1696, 1647, 1016, 803 cm
−1; 
1H and 
13C NMR see 
Table 1; APCIMS m/z 235.1 [M − H]
−; HREIMS m/z 236.1769 [M]
•+ (calcd. for C15H24O2, 236.1771). 
(−)-Sydonol (2): white powder; [α]
25
D −3.6 (c 3.70, CHCl3); UV (MeOH) λmax 198.1, 275.7 nm;  
IR (KBr) νmax 3071, 2946, 2860, 1692, 1640, 1533, 1507, 1407, 1288, 1215, 764 cm
−1; HREIMS  
m/z 252.1719 [M]
•+ (calcd. for C15H24O3, 252.1720). 
(−)-Sydonic acid (3): white powder; [α]
25
D −2.0 (c 1.03, CHCl3); UV (MeOH) λmax 206.3, 253.3, 
304.2 nm; IR (KBr) νmax 3400, 2955, 1670, 1560, 1417, 1325 cm
−1; HREIMS m/z 266.1512 [M]
•+  
(calcd. for C15H22O4, 266.1513). 
(−)-5-(Hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4): white powder; 
[α]
25
D −2.7 (c 1.05, CHCl3); UV (MeOH) λmax 198.1, 280.5 nm; IR (KBr) νmax 3272, 3115, 3039, 2949, 
2872, 1866, 1696, 1619, 1288 cm
−1; HRESIMS m/z 249.1497 [M − H]
− (calcd. for C15H21O3, 249.1491).  Mar. Drugs 2012, 10    
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(Z)-5-(Hydroxymethyl)-2-(6′-methylhept-2′-en-2′-yl)phenol (5): white powder; UV (MeOH)   
λmax 198.1, 236.4, 280.5 nm; IR (KBr) νmax 3272, 3115, 3039, 3005, 1866, 1745, 1647, 1288 cm
−1; 
HRESIMS m/z 233.1540 [M − H]
− (calcd. for C15H21O2, 233.1542). 
4. Conclusions 
In our continuing discovery for biological secondary metabolites from marine sponge-derived fungi 
in the South China Sea, this study provided a series of bisabolane-type sesquiterpenoids. The chiral 
compounds (1–4) possess opposite optical rotation values compared with their related analogues, which 
were isolated from the gorgonian-derived fungi by our group. More importantly, some of them showed 
selective antibacterial activity and significant antifouling activity. Compound 3 exhibited significant 
inhibiting activity to four pathogenic bacteria and uniquely against two marine bacteria. Further studies 
on the structure-activity relationship and structural modification are in progress. 
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